Trial Profile
A Phase Ⅱ Study of S-1 With Concurrent Radiotherapy in Elderly Esophageal Cancer Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Carcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 17 Jun 2019 Planned number of patients changed from 21 to 38.
- 17 Jun 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 17 Jun 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.